Hill P, Cross NB, Barnett ANR, Palmer SC, Webster AC. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Cochrane Database of Systematic Reviews 2017:CD004759.

Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GFM. Dietary patterns for adults with chronic kidney disease. Cochrane Database of Systematic Reviews 2017. Accepted for publication.

Palmer SC, Natale P, Ruospo M, Saglimbene VM, Rabindranath KS, Craig JC, Strippoli GFM. Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. Cochrane Database of Systematic Reviews 2016, Issue 5. Art. No.: CD004541. DOI: 10.1002/14651858.cd004541.pub3.

Bolignano D, Palmer SC, Ruospo M, Zoccali C, Craig JC, Strippoli GF. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database of Systematic Reviews 2015;7:CD010294.

Lo P, Sharma A, Craig JC, Wyburn K, Lim W, Palmer SC, Strippoli GF, Wong G. Preconditioning therapy in ABO-incompatible living kidney transplantation: A systematic review and meta-analysis. Transplantation 100(4):933-42. Impact factor 3.690. Citations: 0.

Vecchio M, Bonarba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database of Systematic Reviews 2015;8:CD003965. Impact factor 6.103. Citations: 0.

Ballinger AE, Palmer SC, Nistor I, Craig JC, Strippoli GF. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database of Systematic Reviews 2014 Dec 9;12. doi: 10.1002/14651858.CD006254.pub2. Epub 2014 Dec 9. Impact factor 5.77. Citations: 11.

Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2014 Dec 8;12:CD010590. doi: 10.1002/14651858.CD010590.pub2. Impact factor 5.77. Citations: 20.

Palmer SC, Palmer AR, Craig JC, Johnson DW, Stroumza P, Frantzen L, Leal M, Hoischen S, Hegbrant J, Strippoli GF. Home versus in-centre haemodialysis for end-stage kidney disease. Cochrane Database of Systematic Reviews 2014 Nov 20;11:CD009535. doi: 10.1002/14651858.CD009535.pub2.

Bolignano D, Palmer SC, Navaneethan SD, Strippoli GFM. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD007004. DOI: 10.1002/14651858.CD007004.pub3.

Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Cross NB, Strippoli GFM. Treatment for peritoneal dialysis associated peritonitis. Cochrane Database of Systematic Reviews 2014, Issue 4. Art No.: CD005284. DOI: 10.1002/14651858.CD005284.pub3.

Palmer SC, Saglimbene V, Craig JC, Navaneethan SD, Strippoli GFM. Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database of Systematic Reviews 2014 Issue 3 Art No.: CD009297. DOI: 10.1002/1461858.CD009297.pub2.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews 2014 May 31;(50:CD007784. DOI: 10.1002/14651858.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegrant J, Strippoli GFM. HMG CoA reductase inhibitors (statins) for kidney transplant recipients (Review). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD005019. DOI: 10.1002/14651858.CD005019.pub4.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database of Systematic Reviews 2014 Jan 28;1:CD005019.

Palmer SC, Rabindranath KS, Craig JC, Roderick PJ, Locatelli F, Strippoli GFM. High-flux versus low-flux membranes for end-stage kidney disease. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD005016. DOI: 10.1002/14651858.CD005016.pub2.

Navaneethan SD, Palmer SC, Vecchio M, Craig J, Elder GJ, Strippoli GF. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients. Cochrane Database of Systematic Reviews 2011 Feb 16;2:CD006023.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GFM. Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD005633. DOI: 10.1002/14651858.CD005633.pub2.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GFM. Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008175. DOI: 10.1002/14651858.CD008175.

Palmer SC, Nand K, Strippoli GF. Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database of Systematic Reviews 2008, Issue 1. Art No.:CD001537. DOI: 10.1002/14651858.CD001537.pub4.

Strippoli GF, Tong A, Palmer SC, Elder G, Craig JC. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Systematic Reviews 2006 Oct 18;(4):CD006254.

Palmer SC, Strippoli GFM, McGregor DO. Interventions to prevent bone disease following renal transplantation. Cochrane Database of Systematic Reviews, Issue 2, 2005 Chichester, UK: John Wiley & Sons, Ltd.